Malcolm Lloyd-Smith, Chief Regulatory Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 6,764 shares at $80.65 ($544K) on 2022-02-07, disclosed to the SEC on 2022-02-09.
Seasonal sale ($544k) by Chief Regulatory Officer — this insider has traded NBIX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.65 | 801 | $65K | 11.9% |
| 2 | $80.65 | 801 | $65K | 11.9% |
| 3 | $80.73 | 1,015 | $82K | 15.1% |
| 4 | $80.73 | 1,015 | $82K | 15.1% |
| 5 | $80.78 | 865 | $70K | 12.8% |
| 6 | $80.78 | 865 |
| $70K |
| 12.8% |
| 7 | $79.53 | 701 | $56K | 10.2% |
| 8 | $79.53 | 701 | $56K | 10.2% |
| Total | $80.48 avg | 6,764 | $544K | 100% |
| Filing → |
| NBIX | SELL | 2022-08-16 | $4.6M | — | Filing → |
| NBIX | SELL | 2021-07-29 | $3.1M | — | Filing → |
| NBIX | SELL | 2021-02-12 | $204K | — | Filing → |